Dara Wright - 16 Dec 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, President, CDG
Signature: /s/ Dara Wright
Issuer symbol: BIO
Transactions as of: 16 Dec 2023
Net transactions value: -$53,265
Form type: 4
Filing time: 19 Dec 2023, 12:19:02 UTC
Previous filing: 12 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO BIOB	Bio-Rad A Common Stock	Options Exercise	$0	+502	+33%	$0.000000	2,001	16 Dec 2023	Direct	F1
transaction	BIO BIOB	Bio-Rad A Common Stock	Tax liability	$53,265	-174	-8.7%	$306.12	1,827	16 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO BIOB	Restricted Stock Units	Options Exercise	$0	-502	-50%	$0.000000	503	16 Dec 2023	Bio-Rad A Common Stock	502	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3	On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.